What liver enzyme levels concern underwriters?

Written by Hannah McCullough Insurance Researcher & Writer

If you have recent lab results and want a starting point, you can see your estimated rate in minutes. An estimate is not an approval or a final policy offer, and a licensed life insurance agent may need more information before discussing next steps.

Which liver tests do underwriters review?

Underwriters may review the liver tests in your application records or an insurer-ordered exam, but the tests do not carry one universal pass-or-fail value. ALT and AST are aminotransferases associated with liver-cell injury. Alkaline phosphatase and GGT can help identify a bile-flow or hepatobiliary pattern. Bilirubin, albumin, and clotting results add context about liver-related health.

AASLD notes that ALT is more specific to liver injury than AST, while AST can also come from skeletal muscle and other organs. That distinction is one reason a single flagged value should not be read as a diagnosis or as a prediction of an insurance offer.

Is there a liver enzyme level that automatically concerns an insurer?

No. Life insurers do not publish one shared cutoff that automatically produces a decline or a particular rate class. An insurer may compare the result with the lab’s upper limit of normal, look at whether it remains abnormal, and weigh it with diagnoses, symptoms, treatment, and other results.

The medical standard is also more careful than a simple number rule. The ACG guideline says an abnormal panel should be repeated or clarified before evaluation. A result that normalizes may lead to a different conversation from a pattern that remains abnormal, but only the insurer can determine how the evidence affects its underwriting decision.

Reference ranges differ by laboratory and test method. The number printed next to your result is therefore more useful than a generic internet threshold. Keep the units and reference range with the report you share. Do not change a prescription, stop drinking, or delay medical care solely to improve an application.

What patterns can lead to more questions?

Persistent or multi-test abnormalities can lead to more questions because they may need an explanation. The same is true when liver chemistry results appear with abnormal bilirubin, albumin, or clotting results, or with a documented liver condition. These findings do not predict a particular offer, but they can make the medical record more important.

AASLD describes hepatocellular, cholestatic, and mixed patterns based on which tests are most elevated. It also lists history, medications, supplements, alcohol use, viral-hepatitis risks, metabolic conditions, and imaging among the factors used to evaluate abnormal results. Those are useful categories for preparing records, not a substitute for medical evaluation.

AST can be elevated for reasons outside the liver, while alkaline phosphatase can have a non-liver source. That is why the pattern and any clarifying tests matter. A life insurance reviewer may ask for records that explain the result rather than treating the lab flag as a complete picture.

How does the cause affect a life insurance review?

The cause, current status, and treatment history usually matter more than an isolated enzyme value. Possible explanations include medication-related injury, alcohol-associated disease, viral hepatitis, metabolic dysfunction-associated steatotic liver disease, autoimmune disease, bile-duct problems, or a non-liver source for one abnormal test. The insurer will assess the information under its own rules.

AASLD’s evaluation framework includes medication and supplement history, alcohol use, viral-hepatitis risks, metabolic disease, blood tests, and abdominal imaging. If a clinician has already identified the cause, the diagnosis, treatment plan, follow-up notes, and trend in results may be more useful than a single old report.

A history of liver disease does not create an automatic answer either. Someone with a resolved cause and stable follow-up may present a different file from someone with active disease or signs of reduced liver function. A prior transplant also changes the records an insurer may request. For that reader, life insurance options after successful liver transplant may involve a separate review of transplant and follow-up history.

What medical information can traditional underwriting use?

Traditional life insurance underwriting can use the information collected in the application, medical records, and an insurer-ordered exam. NAIC explains that traditional underwriting has historically included a physical exam, blood, urine, and saliva testing, along with medical information gathered during the application.

That does not mean every applicant receives every test. The insurer’s process may vary with the requested coverage, age, answers on the application, and the information already available. If a review raises a question, the insurer may ask for an attending physician statement or other records. A licensed agent can explain what the application asks, but cannot promise the underwriting result.

What should you prepare before applying?

Prepare a clean timeline instead of trying to interpret one number in isolation. Include the date of each abnormal result, the test name and units, the laboratory reference range, repeat results, diagnoses, medications and supplements, specialist visits, imaging, and any treatment changes. Keep the original reports so the details are not lost in a summary.

• Recent liver chemistry reports with the laboratory’s reference ranges.
• A medication and supplement list, including recent changes and the reason for each change.
• Relevant physician notes, imaging reports, and follow-up plans.
• A short timeline of symptoms, diagnoses, treatment, and repeat testing.
• Questions about what the insurer needs and how an estimate differs from an approved policy offer.

Answer the application fully and accurately. If a question is unclear, ask for help before submitting it. Do not omit a diagnosis because a later lab result improved. A complete record lets the insurer evaluate the current picture and helps your agent direct the application appropriately.

Can you get life insurance with elevated liver enzymes?

Possibly. Elevated liver enzymes do not automatically disqualify every applicant, but no article can predict an insurer’s decision from a lab value alone. The outcome depends on the cause, persistence, related results, medical history, requested coverage, and the insurer’s underwriting rules.

If a clinician is evaluating an abnormal result, address that health question first. The ACG guideline recommends confirming abnormal liver chemistries, while AASLD describes additional testing and imaging based on the pattern and trajectory. Seek medical care for symptoms or results that concern you. Life insurance preparation should not replace that care.

What is the next step if you are ready to apply?

Start by organizing your reports and writing down the questions an underwriter will need answered: what changed, when it changed, what your clinician found, and whether follow-up results are stable. A licensed life insurance agent can explain the application path and tell you which information is needed for an estimate. The estimate is a starting point, not a promise.

Once your records are ready, review the information for accuracy before you submit an application. Keep copies of the reports you provide. If the insurer asks for more documentation, respond with the requested records rather than guessing at an explanation.

If you want a low-pressure next step, a licensed life insurance agent can review your situation and explain what information may affect an estimate. That conversation can help you decide whether to apply now or first gather more follow-up documentation.